BioSig Technologies, Inc. STEX Cumulative Cost Basis
Cumulative Cost Basis at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s cumulative cost basis.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s cumulative cost basis?
- BioSig Technologies, Inc. (STEX) reported cumulative cost basis of $1.04M in Q1 2026.
- How has BioSig Technologies, Inc.'s cumulative cost basis changed year-over-year?
- BioSig Technologies, Inc.'s cumulative cost basis decreased by 0.0% year-over-year, from $1.04M to $1.04M.
- What is the long-term trend for BioSig Technologies, Inc.'s cumulative cost basis?
- Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s cumulative cost basis has grown at a 18.7% compound annual growth rate (CAGR), from $439K to $1.04M.